Total amount raised
Latest funding date
Location
Justin (Jay) File is the CEO of MEI Pharma, a clinical-stage pharmaceutical company dedicated to developing innovative cancer therapies. With approximately 25 years of diverse accounting and finance experience, File is an adaptive and strategic financial executive with an extensive background in helping biotechnology companies evolve and grow. His deep expertise in corporate accounting, finance, investor relations, and capital markets positions him to lead MEI Pharma through its next stage of development.
Who is the CEO of MEI Pharma?
Justin (Jay) File is an adaptive and strategic financial executive with approximately 25 years of diverse accounting and finance experience. His career spans early-stage biotechnology companies through publicly traded entities, with deep expertise in corporate accounting, finance, investor relations, IT management, and navigating capital markets. File provides executive leadership through all funding stages — from early financing to IPOs and follow-on rounds — ensuring robust financial operations, internal controls, and reporting systems that meet the complex requirements of SEC reporting environments.
A steady and composed leader, File brings clarity and strength in direction to the organizations he leads. He assumed the role of CEO at MEI Pharma in June 2023, bringing his extensive financial and corporate leadership experience to guide the company's strategic direction.
Work History
Justin (Jay) File has built a career spanning executive finance and accounting leadership across the biotechnology and professional services industries. Here are some of the key positions he has held:
- MEI Pharma - CEO (June 2023 - Present)
- Evofem Biosciences - Chief Financial Officer (March 2015 - April 2023)
- WomanCare Global - Chief Financial Officer (November 2017 - May 2018)
- Arthur Andersen - Senior Manager, Finance, Accounting, and Business & Technology Advisory (January 1993 - January 2001)
Education History
Justin (Jay) File earned his degree in Accounting from Central Washington University. This foundation in accounting has been central to his career as a financial executive, equipping him with the technical expertise that underpins his work in corporate finance, SEC reporting, and capital markets across the biotechnology industry.
When did Justin (Jay) File join MEI Pharma?
Justin (Jay) File assumed the role of CEO at MEI Pharma in June 2023. He brings to the position approximately 25 years of accounting and finance experience, including extensive leadership within publicly traded biotechnology companies.
